SCHEMBL6593129

SCHEMBL6593129

Nc1cc(F)c(Cl)cc1C(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 4/20 0.60
NPC1 O15118 4/20 0.56
RAB9A P51151 3/20 0.56
ALDH1A1 P00352 2/20 0.56
LMNA P02545 2/20 0.56
KMT2A Q03164 2/20 0.56
GAA P10253 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
P2RX1 P51575 2/20 0.51
F10 P00742 1/20 0.51
HDAC8 Q9BY41 1/20 0.49
POLB P06746 1/20 0.47
GPR27 Q9NS67 2/20 0.46
PNLIP P16233 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
KCNH2 Q12809 1/20 0.46
BRAF P15056 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6590611 0.91 NPC1 (0.58) FADS1NPC1RAB9AALDH1A1LMNA
SCHEMBL6594140 0.81 FADS1 (0.72) FADS1NPC1RAB9AALDH1A1LMNA
SCHEMBL6593295 0.81 P2RX1 (0.58) FADS1NPC1RAB9AALDH1A1LMNA
SCHEMBL6587131 0.80 FADS1 (0.74) FADS1ALDH1A1LMNAP2RX1POLB
SCHEMBL13362653 0.78 MEN1 (0.53) FADS1NPC1RAB9ALMNAKMT2A
SCHEMBL22720186 0.75 MEN1 (0.55) FADS1NPC1RAB9AALDH1A1LMNA
SCHEMBL15920940 0.75 KMT2A (0.69) FADS1NPC1RAB9AALDH1A1LMNA
SCHEMBL6589803 0.75 FADS1 (0.58) FADS1KMT2AP2RX1F10HDAC8
SCHEMBL4858997 0.74 SMN1; SMN2 (0.67) NPC1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL18145960 0.74 HDAC8 (0.64) NPC1RAB9AALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed